title: Corn oil enhancing hepatic lipid peroxidation induced by CCl4 does not aggravate liver fibrosis in rats.
abstract: Lipid peroxidation (LPO) is known to be associated with liver fibrosis in chronic liver injury. However, direct effects of the products of LPO on liver fibrogenesis have not been demonstrated. In this study, we examined the LPO products of carbon tetrachloride (CCl4)+corn oil to evaluate the effect of LPO products on liver fibrosis. CCl4 was given twice a week for 8 weeks. Corn oil was given daily to rats at a dose of 2 or 10ml/kg via gastrogavage throughout the whole experiment period. CCl4 induced both cyclooxygenase (COX)-2 independent and COX-2 dependent LPO. COX-2 independent LPO was enhanced by corn oil treatment while no effect was reflected on COX-2 dependent LPO. CCl4-induced liver fibrosis in rats was not aggravated by corn oil treatment. In addition, the amount of fatty liver induced by CCl4 was increased by corn oil treatment. Though the inflammation-related UCP-2 mRNA expression was induced by CCl4, it was not aggravated by the enhancement of corn oil.
  
  
  CONCLUSIONS
  corn oil enriches polyunsaturated fatty acids through COX-2 independent pathways to increase LPO products that do not enhance liver fibrosis induced by CCl4.
authors.affiliation: Graduate Institute of Chinese Pharmaceutical Science, College of Pharmacy, China Medical University, Taichung 404, Taiwan.
authors.forename: Hsun-Lang
authors.initials: HL
authors.lastname: Fang
authors.forename: Wen-Chuan
authors.initials: WC
authors.lastname: Lin
mesh_terms: D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D002251:Carbon Tetrachloride / Q000633:toxicity*; D003314:Corn Oil / Q000633:toxicity*; D015237:Dinoprost / Q000031:analogs & derivatives / Q000378:metabolism; D006909:Hydroxyproline / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects*; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology*; D008111:Liver Function Tests; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D050050:Protein Carbonylation / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012709:Serum Albumin / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
chemical_list: D012709:Serum Albumin; D014280:Triglycerides; C075750:8-epi-prostaglandin F2alpha; C026528:15-ketoprostaglandin F2alpha; D008315:Malondialdehyde; D003314:Corn Oil; D015237:Dinoprost; D002251:Carbon Tetrachloride; D001219:Aspartate Aminotransferases; D006909:Hydroxyproline